These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35439348)

  • 21. Treatment of vitiligo using targeted UVB-Intense Pulsed Light (IPL)- phototherapy: evaluation of variables affecting therapeutic success.
    Hartmann A; Schmidt-Habel A; Löhberg L; Zajitschek J; Englbrecht M; Eichner S; Schuler G
    Eur J Dermatol; 2014; 24(5):551-9. PubMed ID: 25445089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo.
    Soliman M; Samy NA; Abo Eittah M; Hegazy M
    J Cosmet Laser Ther; 2016; 18(1):7-11. PubMed ID: 26052813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
    Saraceno R; Nisticò SP; Capriotti E; Chimenti S
    Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up and correlated factors of vitiligo following autologous epidermal transplantation.
    Jin Y; Xu A; Wang P; Song X; Liu X
    Cutis; 2011 Mar; 87(3):137-41. PubMed ID: 21488571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of autologous micrografts on stable bilateral vitiligo: A focus on hand lesions.
    Menchini G; Astarita C
    J Dermatol; 2020 Dec; 47(12):1417-1423. PubMed ID: 32954507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraepidermal injection of dissociated epidermal cell suspension improves vitiligo.
    Khodadadi L; Shafieyan S; Sotoudeh M; Dizaj AV; Shahverdi A; Aghdami N; Baharvand H
    Arch Dermatol Res; 2010 Oct; 302(8):593-9. PubMed ID: 20364383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling.
    Goldstein NB; Steel A; Barbulescu CC; Koster MI; Wright MJ; Jones KL; Gao B; Ward B; Woessner B; Trottier Z; Pakieser J; Hu J; Lambert KA; Shellman YG; Fujita M; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2021 Mar; 141(3):638-647.e13. PubMed ID: 32800877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
    Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
    Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
    Liu LY; Strassner JP; Refat MA; Harris JE; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical repigmentation patterns in paediatric vitiligo.
    Gan EY; Gahat T; Cario-André M; Seneschal J; Ezzedine K; Taïeb A
    Br J Dermatol; 2016 Sep; 175(3):555-60. PubMed ID: 27037527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous repigmentation in vitiligo: why it is important.
    Malakar S; Lahiri K
    Int J Dermatol; 2006 Apr; 45(4):478-9. PubMed ID: 16650185
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
    Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
    Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of efficacy of noncultured hair follicle cell suspension and noncultured epidermal cell suspension in repigmentation of leukotrichia and skin patch in vitiligo: a randomized trial.
    Gunaabalaji DR; Pangti R; Challa A; Chauhan S; Sahni K; Arava SK; Sethuraman G; Vishnubhatla S; Sharma VK; Gupta S
    Int J Dermatol; 2020 Nov; 59(11):1393-1400. PubMed ID: 32989783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short and Long-Term Outcomes of 308-nm Laser for Pediatric Vitiligo.
    Sethi S; Silverberg N
    J Drugs Dermatol; 2022 Jul; 21(7):773-775. PubMed ID: 35816072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicentre, randomized, split face and/or neck comparison of 308-nm excimer laser and 0·1% tacrolimus ointment for stable vitiligo plus intramuscular slow-releasing betamethasone for active vitiligo.
    Wu Y; Sun Y; Qiu L; Wang H; Zhang Y; Chen K; Li H; Gu H; Zhang J; Gao XH
    Br J Dermatol; 2019 Jul; 181(1):210-211. PubMed ID: 30644997
    [No Abstract]   [Full Text] [Related]  

  • 38. Four compartment method as an efficacious and simplified technique for autologous non-cultured epidermal cell suspension preparation in vitiligo surgery: A randomized, active-controlled study.
    Mrigpuri S; Razmi T M; Sendhil Kumaran M; Vinay K; Srivastava N; Parsad D
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):185-190. PubMed ID: 30176093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Action of topical mometasone on the pigmented halos of micrografting in patients with vitiligo.
    Saldanha KD; Machado Filho CD; Paschoal FM
    An Bras Dermatol; 2012; 87(5):685-90. PubMed ID: 23044558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous cellular suspensions and sheets in the treatment of achromic disorders: the need for future controlled studies.
    Ongenae K; van Geel N; Naeyaert JM
    Dermatology; 2001; 202(2):158-61. PubMed ID: 11306847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.